This site is intended for healthcare professionals

BMS presents at UEG week, positive late-breaking data from phase III True North Trial evaluating Zeposia in adult patients with moderate to severe ulcerative colitis

Read time: 1 mins
Last updated:12th Oct 2020
Published:12th Oct 2020
Condition: Ulcerative Colitis
Type: drug
Register free for full access to